Abstract
BACKGROUND: Mycobacterium tuberculosis (Mtb) infection is well known to be challenging to treat. Treatment effectiveness is restricted by the pathogen's inherent drug resistance. A deeper understanding of essential bacterial pathways that influence Mtb growth and survival can expediate the development of more effective therapies from various sources. Here, using mycobacterial tkt gene as a model target, we report on the use of CRISPR interference gene knockdown to potentiate the antimycobacterial activity of selected medicinal plant extracts. METHODS: The growth phenotypes were investigated on solid and liquid media. Broth micro-dilution assay was used to determine minimum inhibitory concentrations. Potential cytotoxicity of the extracts was investigated using Vero cell lines. LC-MS was used for phytochemical analysis. In silico docking was performed on transketolase (Rv1449c), NADH-dependent enoyl-[acyl-carrier-protein] reductase (Rv1484), catalase-peroxidase (Rv1908c). RESULTS: Phenotypic characterisation of the CRISPRi mutants showed that gradual tkt knockdown fully, led to growth disruption. Chemical-genetic interactions showed that tkt knockdown increased the antimycobacterial activity of acetone extracts from Peltophorum africanum and Croton gratissimus by twofold in CRISPRi hypomoprhs. Molecular docking data revealed that Phlorizin from C. gratissimus (-8.1 kcal/mol), Ficus sur tritepernoid (-9.6 kcal/mol) and P. africanum (6-hydroxydelphinidin 3-glucoside) (-8.9 kcal/mol) had the best binding affinities to the TKT active site pocket. Moreover, these compounds had better binding affinities to both NADH-dependent reductase and catalase-peroxidase than Isoniazid. CONCLUSION: The research demonstrated that the mycobacterial tkt gene is crucial for bacterial growth, and CRISPRi-mediated knockdown of this gene enhanced the anti-mycobacterial activity of phyto-compounds, which showed multiple binding affinities to established anti-Mtb targets.